CureVac's mRNA platform

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf mRNA technology
gptkbp:aimsTo improve immune response
gptkbp:develops mRNA vaccines
gptkbp:focusesOn therapeutics
gptkbp:hasClient global vaccine supply
gptkbp:hasCollaboratedWith academic institutions
various pharmaceutical companies
gptkbp:hasFocusOn sustainable development
gptkbp:hasParticipatedIn international collaborations
gptkbp:hasRelatedPatent vaccine development
treat rare diseases
https://www.w3.org/2000/01/rdf-schema#label CureVac's mRNA platform
gptkbp:isAttendedBy mRNA delivery methods
vaccine_hesitancy
gptkbp:isBasedOn lipid nanoparticle delivery system
nucleic acid technology
gptkbp:isChallengedBy new therapeutic modalities
gptkbp:isConsidered next-generation vaccine platform
gptkbp:isDesignedFor target specific antigens
gptkbp:isEnhancedBy patient outcomes
vaccine efficacy
global health security
vaccine safety
gptkbp:isExemplifiedBy combination therapies
gptkbp:isFacilitatedBy rapid vaccine development
gptkbp:isFocusedOn personalized medicine
gptkbp:isIncorporatedIn synthetic biology
gptkbp:isIntegratedWith machine learning
gptkbp:isLedBy data analytics
gptkbp:isLocatedIn clinical data
bioinformatics tools
gptkbp:isPartOf global health initiatives
biotechnology industry
CureVac's_product_pipeline
gptkbp:isPromotedBy public health
gptkbp:isRegulatedBy health authorities
gptkbp:isSimilarTo reduce disease burden
gptkbp:isSupportedBy scientific research
vaccine equity
gptkbp:isTargetedAt autoimmune diseases
gptkbp:isUsedFor therapeutic proteins
gptkbp:isUsedIn cancer treatment
infectious disease treatment
gptkbp:isUtilizedFor immune modulation
gptkbp:isUtilizedIn clinical trials
vaccine research
vaccine technology
gptkbp:isVisitedBy gptkb:CureVac_AG
gptkb:COVID-19_vaccine
gptkbp:translatedInto traditional vaccine approaches
healthcare_delivery
gptkbp:utilizes messenger RNA